The Montreal Neurological Institute-Hospital, also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada.

There are 85 beds in Montreal Neurological Hospital Research Pharmacy.

During the past decade, Montreal Neurological Hospital Research Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Montreal Neurological Hospital Research Pharmacy" are "Parkinson Disease" (1 trials) and "Staphylococcal Vaccine" (1 trials). Many other conditions were trialed in "Montreal Neurological Hospital Research Pharmacy" in a lesser frequency.

Most popular intervention types in "Montreal Neurological Hospital Research Pharmacy" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "PF-06649751 high dose (15 mg QD)" (1 trials), "PF-06649751 low dose (1 mg QD)" (1 trials), "PF-06649751 middle dose 1 (3 mg QD)" (1 trials) and "PF-06649751 middle dose 2 (7 mg QD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Neurological Hospital Research Pharmacy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Neurological Hospital Research Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Montreal Neurological Hospital Research Pharmacy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Neurological Hospital Research Pharmacy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".